RNC Capital Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.21M | Buy |
60,277
+561
| +0.9% | +$39.2K | 0.2% | 61 |
|
|
2025
Q1 | $4.39M | Buy |
59,716
+2,040
| +4% | +$150K | 0.22% | 56 |
|
|
2024
Q4 | $3.78M | Buy |
57,676
+18,207
| +46% | +$1.19M | 0.2% | 59 |
|
|
2024
Q3 | $3.08M | Hold |
39,469
| – | – | 0.17% | 66 |
|
|
2024
Q2 | $3.08M | Buy |
39,469
+3,196
| +9% | +$249K | 0.17% | 66 |
|
|
2024
Q1 | $2.46M | Sell |
36,273
-679
| -2% | -$46K | 0.14% | 69 |
|
|
2023
Q4 | $2.49M | Buy |
36,952
+1,055
| +3% | +$71.1K | 0.15% | 64 |
|
|
2023
Q3 | $2.43M | Sell |
35,897
-695
| -2% | -$47.1K | 0.15% | 66 |
|
|
2023
Q2 | $2.62M | Sell |
36,592
-57,584
| -61% | -$4.12M | 0.14% | 79 |
|
|
2023
Q1 | $6.54M | Sell |
94,176
-4,449
| -5% | -$309K | 0.37% | 41 |
|
|
2022
Q4 | $6.69M | Sell |
98,625
-2,311
| -2% | -$157K | 0.37% | 43 |
|
|
2022
Q3 | $5.54M | Sell |
100,936
-404
| -0.4% | -$22.2K | 0.35% | 45 |
|
|
2022
Q2 | $6.7M | Buy |
101,340
+15,682
| +18% | +$1.04M | 0.38% | 41 |
|
|
2022
Q1 | $5.68M | Buy |
85,658
+32,802
| +62% | +$2.18M | 0.29% | 58 |
|
|
2021
Q4 | $3.08M | Sell |
52,856
-19,713
| -27% | -$1.15M | 0.15% | 81 |
|
|
2021
Q3 | $4.36M | Buy |
72,569
+44,449
| +158% | +$2.67M | 0.23% | 67 |
|
|
2021
Q2 | $1.68M | Buy |
+28,120
| New | +$1.68M | 0.09% | 93 |
|